Loading...
Rapamycin and rapalogs for tuberous sclerosis complex
BACKGROUND: Previous studies have shown potential benefits of rapamycin or rapalogs for treating people with tuberous sclerosis complex. Although everolimus (a rapalog) is currently approved by the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency) for tuberous sclerosis...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2016
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6458010/ https://ncbi.nlm.nih.gov/pubmed/27409709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011272.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|